count in Medical Technology
Navigation Links
count in Medical Technology
... a platelet response defined as a platelet count of 50,000 platelets
per microliter and doubling of the baseline platelet count (median:17,000
platelets per microliter). A ...
-- Platelet counts maintained: Platelet count increases of 50,000
platelets per microliter were ...
... or less frequently. The baseline median platelet count in both the placebo and the PROMACTA groups ... Throughout the study, the median platelet count in the placebo group never exceeded ... arm experienced a rise in their median platelet count to 36,000/microliters, with median platelet ...
... that of the patients with a baseline platelet count of less than 30,000/microliters, 73% achieved a platelet count of greater than or equal to 50,000/microliters. ... time after 3 weeks) in order to reach a platelet count of greater than or equal to 50,000/microliters ...
... cell count, including a differential white cell count and platelet count. Absolute neutrophil count should be > or = 1,500 cells/mm(cubed) and ... Patients should have an absolute granulocyte count of at least 1,500 (x 106/l) prior to initiation ...
... Valcyte tablets should not be administered if the absolute neutrophil count is less than 500 cells/micro liter, the platelet count is less than 25,000/micro liter, or the hemoglobin is less than 8 g/dL. ...
... response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: patient's ... is achieved when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five parameters. ...
... ( arm, (p=not significant). -- Of patients with baseline CD4+ cell count less than 200 cells per cubic millimeter, 79 percent of patients in ... the lopinavir/r arm, (p=0.009). -- Of patients with baseline CD4+ cell count greater than 200 cells per cubic millimeter, 79 percent of patients ...
... HIV viral loads (less than 50 copies/mL) at 48 weeks. CD4+ cell count mean increases over 48 weeks were similar for females and males, ... mean increases in CD4+ cell counts than males. In addition, CD4+ cell count mean increases over 48 weeks were similar for whites and non-whites. At 48 ...
... eligibility criterion for enrollment in the study was that patients' CD4+ count (or T-cell count) had to be greater than or equal to 200 cells/mm3. The mean CD4+ count change from baseline increased by at least 60 cells/mm3 for each of the ...
... response (PR) to a CR/CRu. The side effects reported included blood count suppression: 26 percent and 36 percent grade 3/4 neutropenia, 15 percent ... and 31 percent grade 3/4 thrombocytopenia. Six patients had delayed blood count recovery for more than 12 weeks. One patient developed myelodysplasia and ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is less than 1000 per cubic millimeter. Warnings and Precautions also ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is less than 1000/mm3. Warnings and Precautions also include the risk of ...
... placebo arm [p<0.0001]. -- In DUET-1, the mean increase in CD4+ cell count from baseline was 103 cells/mm3 in the INTELENCE arm compared with 74 ... placebo arm [p=0.0025]. -- In DUET-2, the mean increase in CD4+ cell count from baseline was 94 cells/mm3 in the INTELENCE arm compared with 72 ...
... load of greater than or equal to 5,000 copies/mL; there was no CD4+ cell count restriction for study entry. The primary endpoint for the study was the ... lopinavir/r arm. Immunologic Response * The mean increase in CD4+ count from baseline at 48 weeks was 203 cells/mm3 in patients in the ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is < 1000/mm. Warnings and Precautions also include the risk of ...
... 18 years and older. At screening, male patients must have a CD4+ cell count of <400 cells/mm3 and female patients must have a CD4+ cell count of <250 cells/mm3. Patients will have no prior NRTI or NNRTI use of more ...
... response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: ... when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five ....
... are guided by monitoring plasma HIV-1 levels or viral load, CD4-T cell count and the patient's clinical condition. The goal of antiretroviral therapy ... at the DNA level. Using fluorescent colors and a microscope, physicians count the actual number of HER-2 genes present in the cell nucleus. Results from ...
... baseline viral load of 4.85 log10 copies per mL and a median CD4+ cell count of 225 cells per cubic millimeter. Patients were randomized to receive ... viral load ( lopinavir/r arm. -- The median change in CD4+ cell count from baseline was similar between the PREZISTA/r and lopinavir/r arms ...
... educators, young athletes, and youth sports coaches, according to Timothy Donovan, Executive Director, SUNY Youth Sports Institute. "At a recent count there were nearly 500 energy drink brands. Classified as supplements and aggressively marketed, they have a special allure with young people. This ...
... Neutropenia and Agranulocytosis have been reported with antipsychotics, including risperidone. Patients with a pre-existing low white blood cell count (WBC) or a history of leukopenia/neutropenia should have frequent complete blood cell counts during the first few months of therapy. At the first ...
... for about 96 percent of PPI use in the study. Other PPI's, including rabeprazole (Aciphex(R)), were not included in the study due to the patient count for these agents being insufficient to yield reliable results. Clopidogrel is one of the world's most prescribed drugs, and ranked third in US ...
... trials in the U.S.," said Dr. Naka, who serves as co-principal investigator of the DuraHeart Trial. "It is extremely gratifying for us to count Dr. Naka's team among those elite institutions who are investigating Terumo Heart's DuraHeart System and building the empirical body of evidence to ...
... analysis revealed that nine patients, or 31 percent, of the first 29 evaluable subjects achieved a complete response (CR) or CR without full blood count recovery (CRi). The estimated median overall survival (OS) in responders was 10.5 months compared to 5.1 months in non-responders at the time of the ...
... Marqibo treatment. Safety was assessed in the context of efficacy defined as the achievement of a complete response with or without full blood count recovery. Susan O'Brien, M.D., professor in the leukemia department at the University of Texas MD Anderson Cancer Center in Houston, and ...
... participated in a 48-week study at the University of California, Irvine , and were evaluated through physician assessments of inflammatory lesion count (papules and pustules), severity of erythema (redness) and telangiectasia (spider veins) and overall clinical improvement, as well as through patient ...
... of DOXIL - In patients with recurrent ovarian cancer or AIDS-related Kaposi's sarcoma, hematologic toxicity (based on platelet count or absolute neutrophil count) may require dose reduction or delay in administration of DOXIL - In patients with ...
... response rate in the intent-to-treat (ITT) population was 26 percent, with morphologic CR in 24 percent of patients and CR with incomplete blood count recovery (CRi) in 2 percent. The median time to response was three months, and responses were seen in all subgroups of patients, including patients ...
... activity has been maintained. To date, of 18 evaluable patients, one achieved a CRp and five are hypoplastic and are awaiting hematologic count recovery. Three additional patients with bone marrow blast reductions are undergoing second induction cycles of treatment. Patients on Schedule B ...
... each patient, analysis of the TCD blood-flow speeds in the main arteries of the brain, age at the time of TCD screening, and the most recent blood count and hemoglobin saturation were analyzed. The study found that patients who had lower hemoglobin saturations had higher TCD blood-flow ...
... six months from the beginning of therapy) between the two treatment groups. Secondary objectives included overall safety, initial response (platelet count of 50 x 10^9/L after 30 days of treatment), activity of the salvage therapy (dexamethasone/rituximab) in patients not responding to dexamethasone ...
... do not use PROMACTA in an attempt to normalize platelet counts. Follow the dose adjustment guidelines to achieve and maintain a platelet count of > / = 50 x 10(9)/L. Malignancies and Progression of Malignancies: Stimulation of the TPO receptor on the surface of hematopoietic ...
... viral load (HIV RNA) was -2.1, -2.2, -2.3, -2.3 (log10) at weeks 48, 96, 144 and 168, respectively. Mean change from baseline CD4 (cells/microliter) count was +121, +144, +158 and +143 at the same time points. Key Safety Findings Safety analyses were performed on data from all patients who ...
... or less frequently. The baseline median platelet count in both the placebo and the PROMACTA groups ... Throughout the study, the median platelet count in the placebo group never exceeded ... arm experienced a rise in their median platelet count to 36,000/microliters, with median platelet ...
Soyfoods Do Not Impact Sperm Count
... known that of all semen parameters, variation in count (#s of sperm/cc seminal fluid) is highly variable ... when one considers the "range" of "normal" sperm count accepted in our field (20-200,000 million.)" ... fluid volume with equivalent amounts of sperm count as those with lower intakes, neither the volume ...... that of the patients with a baseline platelet count of less than 30,000/microliters, 73% achieved a platelet count of greater than or equal to 50,000/microliters. ... time after 3 weeks) in order to reach a platelet count of greater than or equal to 50,000/microliters ...
... cell count, including a differential white cell count and platelet count. Absolute neutrophil count should be > or = 1,500 cells/mm(cubed) and ... Patients should have an absolute granulocyte count of at least 1,500 (x 106/l) prior to initiation ...
... Valcyte tablets should not be administered if the absolute neutrophil count is less than 500 cells/micro liter, the platelet count is less than 25,000/micro liter, or the hemoglobin is less than 8 g/dL. ...
New Weight Loss Hope for People with Diabetes
... meal program does not require members visit centers to weigh-in or count carbs, calories or points. "People with diabetes have to perform ... approaches, like featuring low glycemic foods and eliminating the need to count calories, carbs or points. These factors make it easy to stay with the ...... response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: patient's ... is achieved when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five parameters. ...
... ( arm, (p=not significant). -- Of patients with baseline CD4+ cell count less than 200 cells per cubic millimeter, 79 percent of patients in ... the lopinavir/r arm, (p=0.009). -- Of patients with baseline CD4+ cell count greater than 200 cells per cubic millimeter, 79 percent of patients ...
... HIV viral loads (less than 50 copies/mL) at 48 weeks. CD4+ cell count mean increases over 48 weeks were similar for females and males, ... mean increases in CD4+ cell counts than males. In addition, CD4+ cell count mean increases over 48 weeks were similar for whites and non-whites. At 48 ...
... eligibility criterion for enrollment in the study was that patients' CD4+ count (or T-cell count) had to be greater than or equal to 200 cells/mm3. The mean CD4+ count change from baseline increased by at least 60 cells/mm3 for each of the ...
... response (PR) to a CR/CRu. The side effects reported included blood count suppression: 26 percent and 36 percent grade 3/4 neutropenia, 15 percent ... and 31 percent grade 3/4 thrombocytopenia. Six patients had delayed blood count recovery for more than 12 weeks. One patient developed myelodysplasia and ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is less than 1000 per cubic millimeter. Warnings and Precautions also ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is less than 1000/mm3. Warnings and Precautions also include the risk of ...
... placebo arm [p<0.0001]. -- In DUET-1, the mean increase in CD4+ cell count from baseline was 103 cells/mm3 in the INTELENCE arm compared with 74 ... placebo arm [p=0.0025]. -- In DUET-2, the mean increase in CD4+ cell count from baseline was 94 cells/mm3 in the INTELENCE arm compared with 72 ...
... load of greater than or equal to 5,000 copies/mL; there was no CD4+ cell count restriction for study entry. The primary endpoint for the study was the ... lopinavir/r arm. Immunologic Response * The mean increase in CD4+ count from baseline at 48 weeks was 203 cells/mm3 in patients in the ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is < 1000/mm. Warnings and Precautions also include the risk of ...
... 18 years and older. At screening, male patients must have a CD4+ cell count of <400 cells/mm3 and female patients must have a CD4+ cell count of <250 cells/mm3. Patients will have no prior NRTI or NNRTI use of more ...
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is Warnings and Precautions also include the risk of ...... response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: ... when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five ....
... are guided by monitoring plasma HIV-1 levels or viral load, CD4-T cell count and the patient's clinical condition. The goal of antiretroviral therapy ... at the DNA level. Using fluorescent colors and a microscope, physicians count the actual number of HER-2 genes present in the cell nucleus. Results from ...
... baseline viral load of 4.85 log10 copies per mL and a median CD4+ cell count of 225 cells per cubic millimeter. Patients were randomized to receive ... viral load ( lopinavir/r arm. -- The median change in CD4+ cell count from baseline was similar between the PREZISTA/r and lopinavir/r arms ...
Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
... whom month 6 data were unavailable, was considered a treatment failure (ACR non-responder). Disease Activity Scores are based on a 28 joint count and CRP or an ESR at week 24 (depending on which was the qualifying biomarker). Safety Results The most common clinically ...... educators, young athletes, and youth sports coaches, according to Timothy Donovan, Executive Director, SUNY Youth Sports Institute. "At a recent count there were nearly 500 energy drink brands. Classified as supplements and aggressively marketed, they have a special allure with young people. This ...
CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
... published in Cancer , 60,000 cancer patients in the United States are hospitalized for chemotherapy-related neutropenia - or low white blood cell count - which is a risk for serious infection, and a patient dies every two hours from this complication. Healthcare professionals are highly ...... Neutropenia and Agranulocytosis have been reported with antipsychotics, including risperidone. Patients with a pre-existing low white blood cell count (WBC) or a history of leukopenia/neutropenia should have frequent complete blood cell counts during the first few months of therapy. At the first ...
... for about 96 percent of PPI use in the study. Other PPI's, including rabeprazole (Aciphex(R)), were not included in the study due to the patient count for these agents being insufficient to yield reliable results. Clopidogrel is one of the world's most prescribed drugs, and ranked third in US ...
Schering-Plough Announces Results of the Early ACS Trial
... dependent upon renal dialysis (please see dosing guidelines); caution should be exercised when administering INTEGRILIN to patients with a platelet count <100,000/mm3. Bleeding is the most common complication encountered during INTEGRILIN therapy. The majority of excess major bleeding events were ...... trials in the U.S.," said Dr. Naka, who serves as co-principal investigator of the DuraHeart Trial. "It is extremely gratifying for us to count Dr. Naka's team among those elite institutions who are investigating Terumo Heart's DuraHeart System and building the empirical body of evidence to ...
... analysis revealed that nine patients, or 31 percent, of the first 29 evaluable subjects achieved a complete response (CR) or CR without full blood count recovery (CRi). The estimated median overall survival (OS) in responders was 10.5 months compared to 5.1 months in non-responders at the time of the ...
... Marqibo treatment. Safety was assessed in the context of efficacy defined as the achievement of a complete response with or without full blood count recovery. Susan O'Brien, M.D., professor in the leukemia department at the University of Texas MD Anderson Cancer Center in Houston, and ...
... participated in a 48-week study at the University of California, Irvine , and were evaluated through physician assessments of inflammatory lesion count (papules and pustules), severity of erythema (redness) and telangiectasia (spider veins) and overall clinical improvement, as well as through patient ...
US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream
... and HFL, the world's largest sports regulatory and research lab. Glyc'n Go(TM) is available from leading supplement retailers in 60 count and 16-count individual serving packets. For more detailed information visit www.glycngo.com or call toll free 1-877-GLYCNGO. Hi resolution ...... of DOXIL - In patients with recurrent ovarian cancer or AIDS-related Kaposi's sarcoma, hematologic toxicity (based on platelet count or absolute neutrophil count) may require dose reduction or delay in administration of DOXIL - In patients with ...
... response rate in the intent-to-treat (ITT) population was 26 percent, with morphologic CR in 24 percent of patients and CR with incomplete blood count recovery (CRi) in 2 percent. The median time to response was three months, and responses were seen in all subgroups of patients, including patients ...
... activity has been maintained. To date, of 18 evaluable patients, one achieved a CRp and five are hypoplastic and are awaiting hematologic count recovery. Three additional patients with bone marrow blast reductions are undergoing second induction cycles of treatment. Patients on Schedule B ...
... each patient, analysis of the TCD blood-flow speeds in the main arteries of the brain, age at the time of TCD screening, and the most recent blood count and hemoglobin saturation were analyzed. The study found that patients who had lower hemoglobin saturations had higher TCD blood-flow ...
... six months from the beginning of therapy) between the two treatment groups. Secondary objectives included overall safety, initial response (platelet count of 50 x 10^9/L after 30 days of treatment), activity of the salvage therapy (dexamethasone/rituximab) in patients not responding to dexamethasone ...
... do not use PROMACTA in an attempt to normalize platelet counts. Follow the dose adjustment guidelines to achieve and maintain a platelet count of > / = 50 x 10(9)/L. Malignancies and Progression of Malignancies: Stimulation of the TPO receptor on the surface of hematopoietic ...
... viral load (HIV RNA) was -2.1, -2.2, -2.3, -2.3 (log10) at weeks 48, 96, 144 and 168, respectively. Mean change from baseline CD4 (cells/microliter) count was +121, +144, +158 and +143 at the same time points. Key Safety Findings Safety analyses were performed on data from all patients who ...
Other ContentsscurvyallergiesallergiesallergiesallergiesallergiesseasonalseasonalseasonalseasonalseasonalseborrheaseasicknesssebaceoussebaceouskeratoseskeratosisOther TagscommitcommithonoredeMedeMedupsupsupsupsups
(Date:11/4/2009)...- Lowly bacteria, it turns out, hold the power to ... around the world clean up toxic waste on test sit...y RDX, were invented back in World War II and have...se high-energy compounds are often used to propel ...f TNT. , But with increased knowledge of their...
(Date:11/4/2009)....J., Oct. 20 Quest Diagn...ding provider of diagnostic testing, information a...ended September 30, 2009, income from continuing o...ed share, from $160 million, or $0.81 per diluted ...rd quarter results were reduced by a $0.03 per sha...
(Date:11/4/2009)...Calif., Oct. 23 GenVault Corporati...nagement for genomic discovery, medicine and ident...., GenVault,s President and CEO, will be presentin...n October 26th and 27th in La Jolla, CA. ,, Dur...verview of the company together with recent custom...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Prebiotics Add Heart Health Bone Health and Digestive Health Support to Research Proven Cancer Fighting Ability 58335 1Prebiotics Add Heart Health Bone Health and Digestive Health Support to Research Proven Cancer Fighting Ability 58335 2synergIT Presents at VMworld 2009 in San Francisco 58333 1synergIT Presents at VMworld 2009 in San Francisco 58333 2synergIT Presents at VMworld 2009 in San Francisco 58333 3RCRC Independent Review Board Announces DHHS Research Oversight 58331 1RCRC Independent Review Board Announces DHHS Research Oversight 58331 2(Date:11/9/2009)...swire/ -- HUYA Bioscience International, a leade...ion, today announced a strategic partnership with ...ity of China. The agreement is another in a series...China,s leading research and development instituti...t and commercialization of novel biopharmaceutical...
(Date:11/9/2009)...y involving 2,453 women ages 18 to 68 found that l...a partner contributed to higher ratings of pleasur...have long been recommended to women to improve the...isk of vaginal tearing, yet strikingly little avai...ts or associated vaginal symptoms. , The study,...
(Date:11/8/2009)...Newswire-USNewswire/ -- The American Public Health...llness provisions in the health reform bill passed...his bill, the House takes important steps toward u...reforms and moving our health system from one that...on keeping people healthy," said Georges C. Benjam...
(Date:11/8/2009)... out of the game later, doctors say , , ...re the talk of the NFL this season, sidelining suc...k Willie Parker. , Officials at the American Po...f Podiatric Sports Medicine are warning athletes t...ts like football and lacrosse. , "Many fall spo...
(Date:11/8/2009)...book called "Preventing and Healing AIDS Thro...o shows that AIDS is a result of multiple, repeate...mmune system stressor agents, which can be either ...motional. , Oakland, CA ... 2009, cell biologists, physicians, chemists and o...
Breaking Medicine News(10 mins):Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Rx for Fall Foot Injuries 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3[0] HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China[0] Indiana U. at APHA: Studies about why men and women use lubricants during sex[0] APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill[0] Rx for Fall Foot Injuries [0] Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor
FranciscocommithonoredundeniablemodifyinertiareinventiontechnologicaleMedupshonorsleftoverswackiwiki
Other Tagsdocuments 2documents 3documents 4professor 2professor 3professor 4professor 5professor 6professor 7professor 8professor 9professor 10campus 2involves 2involves 3involves 4involves 5involves 6involves 7involves 8involves 9involves 10debate 2debate 3debate 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |